| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 25, 2003
From the Cardiovascular Institute, Loyola University Medical Center, Maywood, Ill (D.J.W., A.C.L., M.B.), and the Cardiology Unit (W.Z., M.W.B., M.L.A., A.J.M.) and Department of Biostatistics (W.J.H.), University of Rochester Medical Center, Rochester, NY. * To whom correspondence should be addressed. E-mail: dwilber{at}lumc.edu.
Background--Prophylactic implantable defibrillators (ICDs) improve survival in patients with impaired ventricular function after myocardial infarction (MI), but it is uncertain whether mortality risk and survival benefit depend on the elapsed time from MI. Methods and Results--The Multicenter Automatic Defibrillator Implantation Trial II examined the impact of ICDs on survival in post-MI patients with ejection fractions Conclusions--Mortality risk in patients with ejection fractions
Revised on January 6, 2004
Accepted on January 16, 2004
Time Dependence of Mortality Risk and Defibrillator Benefit After Myocardial Infarction
David J. Wilber MD*,
30%. In 1159 patients, mean time from most recent MI to enrollment was 81±78 months. Patients were randomized to an ICD (n=699) or conventional care (n=460) in a 3:2 ratio. Mortality rates (deaths per 100 person-years of follow-up) in both treatment groups were analyzed by time from MI divided into quartiles (<18, 18 to 59, 60 to 119, and
120 months). In conventional care patients, these rates increased as time from MI increased (7.8%, 8.4%, 11.6%, 14.0%; P=0.03). Mortality rates in ICD patients were consistently lower in each quartile and showed minimal increase over time (7.2%, 4.9%, 8.2%, 9.0%; P=0.19). Covariate-adjusted hazard ratios for risk of death associated with ICD therapy were 0.97 (95% CI, 0.51 to 1.81; P=0.92) for recent MI (<18 months) and 0.55 (95% CI, 0.39 to 0.78; P=0.001) for remote MI (
18 months).
30% increases as a function of time from MI. The survival benefit associated with ICDs appears to be greater for remote MI and remains substantial for up to
15 years after MI.
Related Article:
Circulation 2004 109: 1073-1075.
This article has been cited by other articles:
![]() |
P. Pascale, J. Schlaepfer, M. Oddo, M.-D. Schaller, P. Vogt, and M. Fromer Ventricular arrhythmia in coronary artery disease: limits of a risk stratification strategy based on the ejection fraction alone and impact of infarct localization Europace, December 1, 2009; 11(12): 1639 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Goldberger and R. Passman Implantable Cardioverter-Defibrillator Therapy After Acute Myocardial Infarction The Results Are Not Shocking. J. Am. Coll. Cardiol., November 24, 2009; 54(22): 2001 - 2005. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Piccini, M. Zhang, K. Pieper, S. D. Solomon, S. M. Al-Khatib, F. Van de Werf, M. A. Pfeffer, J. J.V. McMurray, R. M. Califf, and E. J. Velazquez Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial Eur. Heart J., October 23, 2009; (2009) ehp425v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Garber and M. A. Hlatky The Confirmatory Trial in Comparative-Effectiveness Research N. Engl. J. Med., October 8, 2009; 361(15): 1498 - 1499. [Full Text] [PDF] |
||||
![]() |
R. J. Myerburg, V. Reddy, and A. Castellanos Indications for implantable cardioverter-defibrillators based on evidence and judgment. J. Am. Coll. Cardiol., August 25, 2009; 54(9): 747 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zaman, G. Sivagangabalan, A. Narayan, A. Thiagalingam, D. L. Ross, and P. Kovoor Outcomes of Early Risk Stratification and Targeted Implantable Cardioverter-Defibrillator Implantation After ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention Circulation, July 21, 2009; 120(3): 194 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Daubert Why Are (Only) Some Infarcted Hearts Arrhythmogenic? J. Am. Coll. Cardiol., July 7, 2009; 54(2): 174 - 175. [Full Text] [PDF] |
||||
![]() |
E. M. Aliot, W. G. Stevenson, J. M. Almendral-Garrote, F. Bogun, C. H. Calkins, E. Delacretaz, P. D. Bella, G. Hindricks, P. Jais, M. E. Josephson, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Europace, June 1, 2009; 11(6): 771 - 817. [Full Text] [PDF] |
||||
![]() |
M. Santini, M. Russo, G. Botto, M. Lunati, A. Proclemer, B. Schmidt, A. Erdogan, E. Helmling, W. Rauhe, M. Desaga, et al. Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI) Europace, April 1, 2009; 11(4): 476 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. V. Huikuri, M.J. P. Raatikainen, R. Moerch-Joergensen, J. Hartikainen, V. Virtanen, J. Boland, O. Anttonen, N. Hoest, L. V.A. Boersma, E. S. Platou, et al. Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction Eur. Heart J., March 2, 2009; 30(6): 689 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Eckardt, G.;n. Breithardt, and S. Hohnloser CHAPTER 30 Ventricular Tachycardia and Sudden Cardiac Death ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Myerburg Implantable Cardioverter-Defibrillators after Myocardial Infarction N. Engl. J. Med., November 20, 2008; 359(21): 2245 - 2253. [Full Text] [PDF] |
||||
![]() |
A. S. Adabag, T. M. Therneau, B. J. Gersh, S. A. Weston, and V. L. Roger Sudden Death After Myocardial Infarction JAMA, November 5, 2008; 300(17): 2022 - 2029. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tung, P. Zimetbaum, and M. E. Josephson A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1111 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Epstein Benefits of the Implantable Cardioverter-Defibrillator J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1122 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1179 - 1199. [Full Text] [PDF] |
||||
![]() |
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention Circulation, September 30, 2008; 118(14): 1497 - 1518. [Full Text] [PDF] |
||||
![]() |
D. V. Exner, K. M. Kavanagh, M. P. Slawnych, L. B. Mitchell, D. Ramadan, S. G. Aggarwal, C. Noullett, A. Van Schaik, R. T. Mitchell, M. A. Shibata, et al. Noninvasive Risk Assessment Early After a Myocardial Infarction: The REFINE Study J. Am. Coll. Cardiol., December 11, 2007; 50(24): 2275 - 2284. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K H Lam and A. Owen Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials BMJ, November 3, 2007; 335(7626): 925 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Santini, C. Lavalle, and R. P. Ricci Primary and secondary prevention of sudden cardiac death: who should get an ICD? Heart, November 1, 2007; 93(11): 1478 - 1483. [Full Text] [PDF] |
||||
![]() |
R. Passman and A. Kadish Sudden Death Prevention With Implantable Devices Circulation, July 31, 2007; 116(5): 561 - 571. [Full Text] [PDF] |
||||
![]() |
T. J. Bunch, S. H. Hohnloser, and B. J. Gersh Mechanisms of Sudden Cardiac Death in Myocardial Infarction Survivors: Insights From the Randomized Trials of Implantable Cardioverter-Defibrillators Circulation, May 8, 2007; 115(18): 2451 - 2457. [Full Text] [PDF] |
||||
![]() |
P. J. Zimetbaum A 59-Year-Old Man Considering Implantation of a Cardiac Defibrillator JAMA, May 2, 2007; 297(17): 1909 - 1916. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schober and B. C. Knollmann Exercise After Myocardial Infarction Improves Contractility and Decreases Myofilament Ca2+ Sensitivity Circ. Res., April 13, 2007; 100(7): 937 - 939. [Full Text] [PDF] |
||||
![]() |
A. E. Epstein, C. A. Baessler, A. B. Curtis, N.A. M. Estes III, B. J. Gersh, B. Grubb, and L. B. Mitchell Addendum to "Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/ Scientific Statement From the American Heart Association and the North American Society of Pacing and Electrophysiology" Public Safety Issues in Patients With Implantable Defibrillators A Scientific Statement From the American Heart Association and the Heart Rhythm Society Circulation, March 6, 2007; 115(9): 1170 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Saxon, M. R. Bristow, J. Boehmer, S. Krueger, D. A. Kass, T. De Marco, P. Carson, L. DiCarlo, A. M. Feldman, E. Galle, et al. Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial Circulation, December 19, 2006; 114(25): 2766 - 2772. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gheorghiade, G. Sopko, L. De Luca, E. J. Velazquez, J. D. Parker, P. F. Binkley, Z. Sadowski, K. S. Golba, D. L. Prior, J. L. Rouleau, et al. Navigating the Crossroads of Coronary Artery Disease and Heart Failure Circulation, September 12, 2006; 114(11): 1202 - 1213. [Full Text] [PDF] |
||||
![]() |
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF] |
||||
![]() |
S. Nisam and G. Breithardt Lessons learned from neutral ICD trials Europace, June 1, 2006; 8(6): 393 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pascale, P. Taffe, C. Regamey, L. Kappenberger, and M. Fromer Reduced Ejection Fraction After Myocardial Infarction: Is It Sufficient To Justify Implantation of a Defibrillator? Chest, October 1, 2005; 128(4): 2626 - 2632. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bogun, S. Krishnan, M. Siddiqui, E. Good, J. E. Marine, C. Schuger, H. Oral, A. Chugh, F. Pelosi, and F. Morady Electrogram Characteristics in Postinfarction Ventricular Tachycardia: Effect of Infarct Age J. Am. Coll. Cardiol., August 16, 2005; 46(4): 667 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Buxton, A. J. Moss, A. E. Buxton, and A. J. Moss Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Circulation, May 17, 2005; 111(19): 2537 - 2549. [Full Text] [PDF] |
||||
![]() |
M. B. McClellan and S. R. Tunis Medicare Coverage of ICDs N. Engl. J. Med., January 20, 2005; 352(3): 222 - 224. [Full Text] [PDF] |
||||
![]() |
S. H. Hohnloser, K. H. Kuck, P. Dorian, R. S. Roberts, J. R. Hampton, R. Hatala, E. Fain, M. Gent, S. J. Connolly, and the DINAMIT Investigators Prophylactic Use of an Implantable Cardioverter-Defibrillator after Acute Myocardial Infarction N. Engl. J. Med., December 9, 2004; 351(24): 2481 - 2488. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gillis Prophylactic Implantable Cardioverter-Defibrillators after Myocardial Infarction -- Not for Everyone N. Engl. J. Med., December 9, 2004; 351(24): 2540 - 2542. [Full Text] [PDF] |
||||
![]() |
H. V. Huikuri, J. M. Tapanainen, and T. H. Makikallio Reply J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1529 - 1529. [Full Text] [PDF] |
||||
![]() |
P. Pascale, L. Kappenberger, M. Fromer, D. J. Wilber, A. C. Lin, M. Burke, W. Zareba, M. W. Brown, M. L. Andrews, A. J. Moss, et al. Mortality Risk and Defibrillator Benefit After Myocardial Infarction * Response Circulation, September 14, 2004; 110(11): e304 - e304. [Full Text] [PDF] |
||||
![]() |
ICD Implantation After MI: Does Timing Matter? Journal Watch Cardiology, May 21, 2004; 2004(521): 5 - 5. [Full Text] |
||||
![]() |
E. N. Prystowsky Primary Prevention of Sudden Cardiac Death: The Time of Your Life Circulation, March 9, 2004; 109(9): 1073 - 1075. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |